Reagent Resource Support Program for AIDS Vaccine Development

艾滋病疫苗研发试剂资源支持计划

• 批准号: 9915686
• 负责人: VALERIE FREMONT
• 金额: $ 239.68万
• 依托单位: QUALITY BIOLOGICAL, INC.
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-04-08 至 2020-04-07
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9915686
• 关键词: AIDS Vaccines; Acquired Immunodeficiency Syndrome; Biological Assay; Clinical; Cloning; Contractor; Contracts; Development; Equipment and supply inventories; Funding; Genetic; HIV vaccine; Local Microbicides; Maintenance; Mission; Monoclonal Antibodies; National Institute of Allergy and Infectious Disease; Nongovernmental Organizations; Peptides; Quality Control; Reagent; Research; Research Personnel; Research Priority; Resources; Services; Ships; United States National Institutes of Health; Vaccine Adjuvant; Vaccine Research; Viral Proteins; Virus; cytokine; immunogenicity; novel; polyclonal antibody; pre-clinical; programs; quality assurance; reagent testing; vaccine development; vaccine safety; vector vaccine

The discovery and development of an HIV/AIDS vaccine remains among the highest research priorities of the National Institute of Allergy and Infectious Diseases (NIAID), and is a principal mission of NIAID’s Division of AIDS (DAIDS). To support this mission, NIAID has provided high-quality, novel, and targeted reagents, assays and services for investigators engaged in AIDS vaccine-related research, including NIAID-funded grantees and contractors, other NIH-funded researchers, and investigators supported through various Non-Governmental Organizations (NGOs). These services are provided through this contract by investigator request and NIAID staff approval.

发现和开发艾滋病毒/艾滋病疫苗仍然是国家过敏和传染病研究所的最高研究重点之一，也是国家过敏和传染病研究所艾滋病司的一项主要任务。为了支持这一任务，美国国立艾滋病研究所为从事艾滋病疫苗相关研究的研究人员提供了高质量、新颖和有针对性的试剂、检测和服务，包括美国国立艾滋病研究所资助的受助人和承包商、其他美国国立艾滋病研究所资助的研究人员以及通过各种非政府组织支持的研究人员。这些服务是根据研究者的要求和NIAID工作人员的批准通过本合同提供的。